Induction chemotherapy with carboplatin, nab-paclitaxel and cetuximab for at least N2b nodal status or surgically unresectable squamous cell carcinoma of the head and neck. [electronic resource]
Producer: 20191115Description: 46-51 p. digitalISSN:- 1879-0593
- Adult
- Aged
- Albumins -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carboplatin -- administration & dosage
- Cetuximab -- administration & dosage
- Chemoradiotherapy -- adverse effects
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- Drug Eruptions -- etiology
- Female
- Head and Neck Neoplasms -- drug therapy
- Humans
- Induction Chemotherapy
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Neoadjuvant Therapy -- adverse effects
- Neoplasm Staging
- Neutropenia -- chemically induced
- Paclitaxel -- administration & dosage
- Progression-Free Survival
- Radiotherapy, Intensity-Modulated -- adverse effects
- Squamous Cell Carcinoma of Head and Neck -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.